25 May 2013
Keywords: ucb, sells, somatostatine, eumedica, belgian, drugmaker, agreed
Article | 16 February 2009
Belgian drugmaker UCB has agreed to sell the worldwide rights for Somatostatine-UCB to France's Eumedica. UCB will receive a cash
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
16 February 2009
24 May 2013
© 2013 thepharmaletter.com